OPS

or

Free TMS or Spravato® consultations for patients with treatment-resistant depression

Spravato® (Esketamine) for Treatment-Resistant Depression in Columbus & Lancaster, Ohio

Spravato Esketamine for Depression

If you’ve tried multiple antidepressants and still feel stuck in a depressive episode, you may be experiencing treatment-resistant depression (TRD). This is a recognized medical condition, not a personal failure, and it affects many individuals living with major depressive disorder. Treatments like Spravato (esketamine) offer new hope for people who have not responded well to traditional antidepressant medications.

Spravato (esketamine) nasal spray is an FDA-approved treatment specifically designed for adults with TRD. For those searching for advanced depression treatment in Columbus or Lancaster, Ohio, Spravato offers a different and often faster-acting approach compared to traditional medications.

How Spravato Works Differently Than Antidepressants

Most antidepressants work by gradually increasing serotonin or norepinephrine levels over several weeks. Spravato works on a completely different pathway, the glutamate system.

  • Temporarily blocks NMDA receptors
  • Triggers a surge in glutamate
  • Activates AMPA receptors
  • Increases brain-derived neurotrophic factor (BDNF)
  • Promotes neuroplasticity (the brain’s ability to form new, healthier connections)

This process helps the brain “reset” patterns associated with depression, rather than simply adjusting chemical levels.

Because of this mechanism, many patients experience improvement much faster than with traditional antidepressants.

How Quickly Does Spravato Work?

One of the biggest advantages of Spravato treatment in Columbus and Lancaster, Ohio, is how quickly it can begin to relieve symptoms.

Typical Timeline

  • Within 24 hours: Some patients notice reduced emotional heaviness or suicidal thoughts
  • 1–2 weeks: More consistent improvement in mood and energy
  • Around 4 weeks: Significant symptom reduction for many patients

Clinical trials and real-world data show rapid improvement within 24 hours and continued progress over several weeks.

Response varies from person to person and depends on factors such as prior treatment history, duration of depression, and overall care plan.

How Effective Is Spravato for Treatment-Resistant Depression?

Research shows that Spravato can be highly effective for patients who have not responded to at least two antidepressants.

Key Findings

  • Rapid symptom relief often within the first 24 hours
  • Sustained improvement over 4–12 weeks and beyond
  • Long-term stability in many patients, even after treatment tapering

In 2025, the FDA approved Spravato as the first and only monotherapy for treatment-resistant depression, meaning it can be used on its own or alongside oral antidepressants.

Patients who respond often report:

  • Improved mood
  • Clearer thinking
  • Increased energy
  • Renewed interest in daily activities
  • Better emotional connection with others

What to Expect from Spravato Treatment at OPS

At Ohio Psychiatric Services, we provide Spravato treatment in Columbus (Hilliard) and Lancaster, Ohio, in a structured, safe, and supportive environment.

1. Comprehensive Evaluation

A provider reviews your history, medications, and overall health to determine if Spravato is appropriate.

2. Insurance Coordination

Our team handles prior authorization and benefits verification, including manufacturer assistance programs when available.

3. Induction Phase (First 4 Weeks)

  • Twice-weekly treatments
  • Self-administered nasal spray under supervision
  • 2-hour in-office monitoring after each session (REMS requirement)

4. Maintenance Phase

  • Weekly → then every 1–2 weeks
  • Adjusted based on symptom stability
  • Goal: maintain results with the least frequent dosing

Because of temporary side effects, you will need a ride home after each session and should not drive the rest of the day.

Safety, Side Effects, and Monitoring

Spravato is only administered in certified clinics under a strict REMS (Risk Evaluation and Mitigation Strategy) program.

Common Short-Term Side Effects

  • Dissociation (“floaty” or disconnected feeling)
  • Dizziness
  • Nausea
  • Temporary increase in blood pressure
  • Sleepiness or sedation

These effects typically:

  • Begin shortly after dosing
  • Resolve within 1–2 hours
  • Decrease over time with continued treatment

Spravato may not be appropriate for individuals with:

  • Certain vascular conditions
  • History of brain hemorrhage
  • Ketamine/esketamine allergy
  • Pregnancy

Your provider will carefully review risks and determine if treatment is safe for you.

Comprehensive Depression Treatment in Columbus & Lancaster, Ohio

At Ohio Psychiatric Services, Spravato is part of a personalized, integrated depression treatment plan, which may include:

  • Spravato treatment (Columbus & Lancaster)
  • TMS therapy in Hilliard & Lancaster
  • Medication management
  • Counseling and psychotherapy
  • Psychiatric evaluations
  • Genetic testing

This approach ensures your treatment is tailored to your specific needs-whether that includes Spravato, TMS, medication adjustments, or a combination.

Start Spravato Treatment Near You

If depression hasn’t improved with traditional medications, Spravato may offer a faster and more effective path forward.

Ohio Psychiatric Services specializes in Spravato treatment in Columbus (Hilliard) and Lancaster, Ohio, helping patients find relief when other treatments haven’t worked.

Call our office or request an appointment online today to see if Spravato is right for you.